Suppressor of cytokine signaling 3 is an inducible host factor that regulates virus egress during Ebola virus infection

Journal of Virology

Volumn 89, Issue 20, 2015, Pages 10399-10406

  Okumura, Atsushi ^a,d   Rasmussen, Angela L ^a   Halfmann, Peter ^c   Feldmann, Friederike ^d   Yoshimura, Akihiko ^e   Feldmann, Heinz ^d   Kawaoka, Yoshihiro ^c,f,g   Harty, Ronald N ^h   Katze, Michael G ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Washington National Primate Research Center   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN MD 2; PROTEIN VP40; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 4; CORE PROTEIN; DNA BINDING PROTEIN; ESCRT PROTEIN; GLYCOPROTEIN; NEDD4 UBIQUITIN PROTEIN LIGASES; NUCLEOPROTEIN; NUCLEOPROTEIN VP40, EBOLA VIRUS; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TLR4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EMBRYO; IMMUNE EVASION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; VIRUS RELEASE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL LINE; EBOLAVIRUS; FEEDBACK SYSTEM; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; MACROPHAGE; METABOLISM; SIGNAL TRANSDUCTION; VIRION; VIROLOGY;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; EBOLAVIRUS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEEDBACK, PHYSIOLOGICAL; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GLYCOPROTEINS; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; NUCLEOPROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; VIRAL CORE PROTEINS; VIRION; VIRUS RELEASE;

EID: 84942154620     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01736-15     Document Type: Article

References (51)

1. Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ. 1996. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 70:2208-2214.
2. Bray M, Geisbert TW. 2005. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 37:1560-1566. http://dx.doi.org/10.1016/j.biocel.2005.02.018.
3. Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ. 2001. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol 75:10623-10629. http://dx.doi.org/10.1128/JVI.75.22.10623-10629.2001.
4. Craven RC, Harty RN, Paragas J, Palese P, Wills JW. 1999. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J Virol 73:3359-3365.
5. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad SciUSA97:13871-13876. http://dx.doi.org/10.1073/pnas.250277297.
6. Harty RN, Paragas J, Sudol M, Palese P. 1999. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 73:2921-2929.
7. Jayakar HR, Murti KG, Whitt MA. 2000. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 74:9818-9827. http://dx.doi.org/10.1128/JVI.74.21.9818-9827.2000.
8. Timmins J, Schoehn G, Ricard-Blum S, Scianimanico S, Vernet T, Ruigrok RW, Weissenhorn W. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol 326:493-502. http://dx.doi.org/10.1016/S0022-2836(02)01406-7.
9. Yang Z, Delgado R, Xu L, Todd RF, Nabel EG, Sanchez A, Nabel GJ. 1998. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 279:1034-1037. http://dx.doi.org/10.1126/science.279.5353.1034.
10. Licata JM, Johnson RF, Han Z, Harty RN. 2004. Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 viruslike particles. J Virol 78:7344-7351. http://dx.doi.org/10.1128/JVI.78.14.7344-7351.2004.
11. Bosio CM, Moore BD, Warfield KL, Ruthel G, Mohamadzadeh M, Aman MJ, Bavari S. 2004. Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology 326:280-287. http://dx.doi.org/10.1016/j.virol.2004.05.025.
12. Wahl-Jensen V, Kurz SK, Hazelton PR, Schnittler HJ, Stroher U, Burton DR, Feldmann H. 2005. Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol 79:2413-2419. http://dx.doi.org/10.1128/JVI.79.4.2413-2419.2005.
13. Martinez O, Valmas C, Basler CF. 2007. Ebola virus-like particleinduced activation of NF-κB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain. Virology 364:342-354. http://dx.doi.org/10.1016/j.virol.2007.03.020.
14. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A 105:3974-3979. http://dx.doi.org/10.1073/pnas.0710629105.
15. Malakhova OA, Zhang DE. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 283:8783-8787. http://dx.doi.org/10.1074/jbc.C800030200.
16. Qureshi ST, Gros P, Malo D. 1999. Host resistance to infection: genetic control of lipopolysaccharide responsiveness by Toll-like receptor genes. Trends Genet 15:291-294. http://dx.doi.org/10.1016/S0168-9525(99)01782-5.
17. Beutler B. 2000. Endotoxin, Toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 3:23-28. http://dx.doi.org/10.1016/S1369-5274(99)00046-6.
18. Okumura A, Pitha PM, Yoshimura A, Harty RN. 2010. Interaction between Ebola virus glycoprotein and host Toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. J Virol 84:27-33. http://dx.doi.org/10.1128/JVI.01462-09.
19. Yoshimura A, Naka T, Kubo M. 2007. SOCS proteins, cytokine signaling and immune regulation. Nat Rev Immunol 7:454-465. http://dx.doi.org/10.1038/nri2093.
20. Dalpke A, Heeg K, Bartz H, Baetz A. 2008. Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology 213:225-235. http://dx.doi.org/10.1016/j.imbio.2007.10.008.
21. Yasukawa H, Sasaki A, Yoshimura A. 2000. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18:143-164. http://dx.doi.org/10.1146/annurev.immunol.18.1.143.
22. Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, Kitamura T, Kato H, Nakayama K, Yoshimura A. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 276:12530-12538. http://dx.doi.org/10.1074/jbc.M010074200.
23. Kamura T, Sato S, Haque D, Liu L, Kaelin WG, Jr, Conaway RC, Conaway JW. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12:3872-3881. http://dx.doi.org/10.1101/gad.12.24.3872.
24. Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN. 2003. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol 77:1812-1819. http://dx.doi.org/10.1128/JVI.77.3.1812-1819.2003.
25. Hill-Batorski L, Halfmann P, Neumann G, Kawaoka Y. 2013. The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication. J Virol 87:13795-13802. http://dx.doi.org/10.1128/JVI.02422-13.
26. Warfield KL, Perkins JG, Swenson DL, Deal EM, Bosio CM, Aman MJ, Yokoyama WM, Young HA, Bavari S. 2004. Role of natural killer cells in innate protection against lethal Ebola virus infection. J Exp Med 200:169-179. http://dx.doi.org/10.1084/jem.20032141.
27. Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, Conaway RC, Conaway JW, Nakayama KI. 2004. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18:3055-3065. http://dx.doi.org/10.1101/gad.1252404.
28. Sasaki A, Inagaki-Ohara K, Yoshida T, Yamanaka A, Sasaki M, Yasukawa H, Koromilas AE, Yoshimura A. 2003. The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6. J Biol Chem 278:2432-2436. http://dx.doi.org/10.1074/jbc.C200608200.
29. Cardenas WB, Loo YM, Gale M, Jr, Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EO, Basler CF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 80:5168-5178. http://dx.doi.org/10.1128/JVI.02199-05.
30. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, Carbonnelle C, Volchkov VE, Nichol ST, Basler CF. 2006. Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation. J Virol 80: 5156-5167. http://dx.doi.org/10.1128/JVI.02349-05.
31. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, Bray M, Klenk HD, Palese P, Garcia-Sastre A. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77:7945-7956. http://dx.doi.org/10.1128/JVI.77.14.7945-7956.2003.
32. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 103:1440-1445. http://dx.doi.org/10.1073/pnas.0510518103.
33. Bourette RP, De Sepulveda P, Arnaud S, Dubreuil P, Rottapel R, Mouchiroud G. 2001. Suppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signal. J Biol Chem 276:22133-22139. http://dx.doi.org/10.1074/jbc.M101878200.
34. Ryo A, Tsurutani N, Ohba K, Kimura R, Komano J, Nishi M, Soeda H, Hattori S, Perrem K, Yamamoto M, Chiba J, Mimaya J, Yoshimura K, Matsushita S, Honda M, Yoshimura A, Sawasaki T, Aoki I, Morikawa Y, Yamamoto N. 2008. SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc Natl Acad Sci U S A 105:294-299. http://dx.doi.org/10.1073/pnas.0704831105.
35. Pauli EK, Schmolke M, Wolff T, Viemann D, Roth J, Bode JG, Ludwig S. 2008. Influenza A virus inhibits type I IFN signaling via NF-κB dependent induction of SOCS-3 expression. PLoS Pathog 4:e1000196. http://dx.doi.org/10.1371/journal.ppat.1000196.
36. Akhtar LN, Benveniste EN. 2011. Viral exploitation of host SOCS protein functions. J Virol 85:1912-1921. http://dx.doi.org/10.1128/JVI.01857-10.
37. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E. 2002. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128:163-168. http://dx.doi.org/10.1046/j.1365-2249.2002.01800.x.
38. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088. http://dx.doi.org/10.1126/science.282.5396.2085.
39. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189:615-625. http://dx.doi.org/10.1084/jem.189.4.615.
40. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752.
41. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689-10692. http://dx.doi.org/10.1074/jbc.274.16.10689.
42. Zimmermann S, Murray PJ, Heeg K, Dalpke AH. 2006. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling. J Immunol 176:1840-1847. http://dx.doi.org/10.4049/jimmunol.176.3.1840.
43. Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94:14764-14769. http://dx.doi.org/10.1073/pnas.94.26.14764.
44. Wool-Lewis RJ, Bates P. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 72:3155-3160.
45. Simmons G, Rennekamp AJ, Chai N, Vandenberghe LH, Riley JL, Bates P. 2003. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 77:13433-13438. http://dx.doi.org/10.1128/JVI.77.24.13433-13438.2003.
46. Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y. 2000. Downregulation of β1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278:20-26. http://dx.doi.org/10.1006/viro.2000.0601.
47. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. 2006. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 80:10109-10116. http://dx.doi.org/10.1128/JVI.01157-06.
48. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131:1124-1136. http://dx.doi.org/10.1016/j.cell.2007.10.034.
49. Zhao DC, Yan T, Li L, You S, Zhang C. 2007. Respiratory syncytial virus inhibits interferon-alpha-inducible signaling in macrophage-like U937 cells. J Infect 54:393-398. http://dx.doi.org/10.1016/j.jinf.2006.06.005.
50. Miyoshi H, Fujie H, Shintani Y, Tsutsumi T, Shinzawa S, Makuuchi M, Kokudo N, Matsuura Y, Suzuki T, Miyamura T, Moriya K, Koike K. 2005. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J Hepatol 43:757-763. http://dx.doi.org/10.1016/j.jhep.2005.03.028.
51. Mahller YY, Sakthivel B, Baird WH, Aronow BJ, Hsu YH, Cripe TP, Mehrian-Shai R. 2008. Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication. Cancer Gene Ther 15:733-741. http://dx.doi.org/10.1038/cgt.2008.40.